Technical Analysis for NXS - Next Science Limited

Grade Last Price % Change Price Change
F 0.142 5.19% 0.007
NXS closed up 5.19 percent on Thursday, November 21, 2024, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish 5.19%
Stochastic Reached Oversold Weakness 5.19%
Gapped Up Strength 5.19%

   Recent Intraday Alerts

Alert Time
Up 5% about 10 hours ago
Possible Inside Day about 10 hours ago
Possible NR7 about 10 hours ago
Gap Up Partially Closed about 13 hours ago
Gapped Up (Partial) about 14 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Next Science Limited Description

Next Science Limited is an Australia-based medical technology company. The Company focuses on the development and commercialization of its Xbio technology to reduce the impact of biofilm-based infections in human health. Its products include Bactisure Surgical Lavage, BlastX Antimicrobial Wound Gel, TorrentX Wound Wash, SurgX Sterile Antimicrobial Wound Gel for Surgical Site Infections and Acne Treatment. The SurgX is a surgical gel designed to help reduce superficial surgical site infections (SSIs) and protect wound tissue to facilitate natural healing. Its Bactisure is designed to remove structurally resistant forms of bacteria (biofilm) through physical deconstruction of the extracellular polymeric substance (EPS) matrix, making bacteria more susceptible to traditional antibiotics and the body’s normal defense mechanisms. BlastX is an antimicrobial wound gel and deconstructs the bacterial biofilm, the gel envelops and eliminates the bacteria.


Classification

Sector: Basic Materials
Industry: Independent Oil & Gas
Keywords: Health Construction Biology Medical Technology Sms Film Infection Bacteria Wound Bacteriology Microbiology Antibiotic Antibiotics Antimicrobial Healing Infections Acne Bio Technology Environmental Microbiology

Is NXS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.47
52 Week Low 0.115
Average Volume 223,081
200-Day Moving Average 0.265
50-Day Moving Average 0.172
20-Day Moving Average 0.145
10-Day Moving Average 0.144
Average True Range 0.014
RSI (14) 45.36
ADX 20.21
+DI 14.301
-DI 25.533
Chandelier Exit (Long, 3 ATRs) 0.129
Chandelier Exit (Short, 3 ATRs) 0.166
Upper Bollinger Bands 0.158
Lower Bollinger Band 0.132
Percent B (%b) 0.4
BandWidth 17.842
MACD Line -0.009
MACD Signal Line -0.010
MACD Histogram 0.0012
Fundamentals Value
Market Cap 27.58 Million
Num Shares 194 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -1.78
Price-to-Sales 55.88
Price-to-Book 12.92
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.145
Resistance 3 (R3) 0.145 0.143 0.145
Resistance 2 (R2) 0.143 0.143 0.144 0.144
Resistance 1 (R1) 0.143 0.142 0.143 0.143 0.144
Pivot Point 0.141 0.141 0.142 0.142 0.141
Support 1 (S1) 0.141 0.141 0.141 0.141 0.140
Support 2 (S2) 0.139 0.140 0.140 0.140
Support 3 (S3) 0.139 0.139 0.140
Support 4 (S4) 0.139